Proctosan supp. rectal # 10

Suppositories are light yellow-green in color.

Pharmaco-therapeutic group

N4 Hemorrhoids 1st and 2nd degree, anal fissures, acute and chronic anal eczema, inflammatory processes in the rectum (proctitis)

Application during pregnancy and during breastfeeding

Dosage form

Rectal suppositories.

5 suppositories in a blister strip packaging.

2 blister strip packaging together with instructions for medical use of the drug are placed in a cardboard box.

Shelf life

5 years.

Do not use the drug after the expiration date printed on the package.

Category

Proctology

Name ENG

PROCTOSAN

Clinical and pharmacological group

A drug with anti-inflammatory, astringent, drying and local anesthetic action for local use in proctology

ATX code

Bismuth compounds in combination with other drugs

Dosage

50 mg + 50 mg + 50 mg + 5 mg

Structure

1 candle contains: bufexamak - 250 mg, bismuth subgallate - 100 mg, titanium dioxide - 100 mg, lidocaine hydrochloride hydrate - 10 mg Excipient: solid fat - 1540 mg

Indications

hemorrhoids 1 and 2 degrees

cracks in the anus

acute and chronic anal eczema

inflammatory processes in the rectal area (including proctitis).

INN / Active ingredient

Bufexamak + Bismuth subgallate + Titanium dioxide + Lidocaine hydrochloride hydrate

Contraindications

Hypersensitivity to the components of the drug, specific inflammatory processes (syphilis, tuberculosis), childhood, pregnancy, lactation.

Storage conditions and periods

At a temperature not higher than 25 ° C.

Keep out of the reach of children.

Specifications

Category

Hemorrhoids

Scope of the drug

General

Release form

Suppositories

Manufacturer country

Germany

Package quantity, pcs

ten

Scope of application

Proctology

Way of introduction

Rectally

Vacation conditions

Without recipe

Brand name

Stada

The amount of the dosage form in the primary package

5 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Hemorrhoid remedy

Dosage form

Rectal suppositories

Expiration date in days

1825

Package weight, g

fifty

Mode of application

:

Apply rectally 1 suppository 1-2 times a day, if possible after bowel movement.

It is recommended to continue using the drug after the acute symptoms have subsided for 8 to 10 days.

Anatomical and therapeutic characteristics

:

C05AX02 Bismuth drugs, in combination with other drugs